» Articles » PMID: 39822330

Hybrid Care Model: Combining Telemedicine and Office Visits for Diabetes Management in Older Adults with Type 1 Diabetes

Overview
Journal Med Res Arch
Date 2025 Jan 17
PMID 39822330
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To evaluate the use of hybrid (telehealth and in-person) care on visitation and glycaemia in older adults with type 1 diabetes (T1D).

Methods: In this retrospective study, we examined clinical characteristics, number of visits (telehealth and in-person) and continuous glucose monitoring (CGM) metrics for older adults (≥65 years) with T1D from electronic health records during the pre-COVID-19 pandemic (March 1, 2019-March 1, 2020; in-person) and pandemic (September 1, 2020-August 31, 2021; hybrid) periods. Main outcomes were the number of visits and changes in glycaemic control (HbA1c), and in a sub-group of older adults using CGM, changes in CGM metrics between in-person and hybrid care.

Results: We analysed data of 661 older adults with T1D (age 72±5 years). The hybrid care resulted in an increased number of annual diabetes visits (6.3 vs 4.2 visits/person) without change in glycaemic control (HbA1c 7.4% vs 7.2%) compared with in-person care alone. In the sub-group of 299 older adults with T1D using CGM, hybrid care compared with in-person care resulted in an improvement of time-in-range (70-180 mg/dL) (68% to 71%; p<0.001) without increasing hypoglycaemia (<70 mg/dL).

Conclusion: Compared with in-person only visits, hybrid care maintained visit frequency and preserved glycaemic control measured as HbA1c. In a sub-group of older adults with T1D using CGM, time-in-range improved while time in hypoglycaemia did not change. These data suggest that a hybrid care model is efficacious in maintaining visitation and glycaemic control, and, as demonstrated in a sub-group of older adults with T1D using CGM, safe with respect to time in hypoglycaemia.

References
1.
Kaushal T, Tinsley L, Volkening L, Turcotte C, Laffel L . Improved CGM Glucometrics and More Visits for Pediatric Type 1 Diabetes Using Telemedicine During 1 Year of COVID-19. J Clin Endocrinol Metab. 2022; 107(10):e4197-e4202. PMC: 9516076. DOI: 10.1210/clinem/dgac476. View

2.
Lee J, Lee S . Telemedicine Cost-Effectiveness for Diabetes Management: A Systematic Review. Diabetes Technol Ther. 2018; 20(7):492-500. DOI: 10.1089/dia.2018.0098. View

3.
Bertuzzi F, Stefani I, Rivolta B, Pintaudi B, Meneghini E, Luzi L . Teleconsultation in type 1 diabetes mellitus (TELEDIABE). Acta Diabetol. 2017; 55(2):185-192. DOI: 10.1007/s00592-017-1084-9. View

4.
Xu T, Pujara S, Sutton S, Rhee M . Telemedicine in the Management of Type 1 Diabetes. Prev Chronic Dis. 2018; 15:E13. PMC: 5800428. DOI: 10.5888/pcd15.170168. View

5.
Sotomayor F, Hernandez R, Malek R, Parimi N, Spanakis E . The Effect of Telemedicine in Glycemic Control in Adult Patients with Diabetes during the COVID-19 Era-A Systematic Review. J Clin Med. 2023; 12(17). PMC: 10489036. DOI: 10.3390/jcm12175673. View